SignalXSignalX

Verastem, Inc. (VSTM) 8-K Current Report — March 4, 2026

Filed: March 4, 2026
Health Care
Pharmaceutical Preparations
Verastem, Inc. Overview

Verastem, Inc. (VSTM) 8-K current report filed with SEC EDGAR on March 4, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 7.01: Regulation FD Disclosure

Verastem, Inc. 8-K Mar 4, 2026 Event Analysis

Item 7.01 · Regulation FD Disclosure

  • • Updated corporate presentation posted March 4, 2026 — full content in Exhibit 99.1
  • • Reg FD disclosure ensures simultaneous public access; presentation likely contains pipeline, clinical, or financial updates material to investors

Get deeper insights on Verastem, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.